Yahoo! Finance Search - Finance Home - Yahoo! - Help

Saturday, November 29 2014 3:45am ET - U.S. Markets Closed.
Industry Center - Drug Manufacturers - Other
Industry Center > Drug Manufacturers - Other > News
More On This Industry
· Summary
News
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Diagnostic Substances
· Drug Delivery
· Drug Manufacturers - Major
· Drug Related Products
· Drugs - Generic
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Biotechnology
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Conglomerates
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
 
Drug Manufacturers - Other News
Latest News
Friday, Nov 28, 2014
·Dynavax Regains Full Rights to Investigational TLR 7/9 Inhibitor DV1179 Following Expiration of Collaboration With GSK
Marketwire - Fri 6:00 am ET
·Earnings Estimates Moving Higher for Amphastar Pharmaceuticals (AMPH): Time to Buy?
Zacks.com - Fri 5:40 am ET
Wednesday, Nov 26, 2014
·Prof. Yitzhak Peterburg Elected Chairman of Teva’s Board of Directors
Business Wire - Wed Nov 26
·MEI Pharma To Host Annual Meeting Of Stockholders
PR Newswire - Wed Nov 26
·Ackman's Pershing Square still holds 26.6 million Allergan shares
Reuters - Wed Nov 26
·Orexigen Therapeutics to Present at the Piper Jaffray Healthcare Conference
PR Newswire - Wed Nov 26
·[$$] Novo Could Put Money Where Its Mouth Is
at The Wall Street Journal Online - Wed Nov 26
Tuesday, Nov 25, 2014
·Researchers Report Thymosin Beta 4 is Cardioprotective in Pulmonary Hypertension/Heart Failure Model
PR Newswire - Tue Nov 25
·Isis Pharmaceuticals Initiates Phase 3 Study of ISIS-SMN Rx in Children With Spinal Muscular Atrophy
PR Newswire - Tue Nov 25
·Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 26th Annual Piper Jaffray Healthcare Conference
GlobeNewswire - Tue Nov 25
Monday, Nov 24, 2014
·Actavis mulls job cuts, China expansion - Bloomberg
Reuters - Mon Nov 24
·Salix Plans to Boost Size of Board
at The Wall Street Journal Online - Mon Nov 24
·Investors Who Sold Allergan (AGN) Shares Between April 1, 2014 and April 21, 2014 May Contact Gardy & Notis, LLP Law Firm For Further Information
PR Newswire - Mon Nov 24
·AstraZeneca Loses Bid to End `Pay-For-Delay' Nexium Trial
at Bloomberg - Mon Nov 24
·Actavis-Allergan: Anatomy of a $66B Deal
at Bloomberg - Mon Nov 24
·Pernix Therapeutics Inc. to Present at the 26th Annual Piper Jaffray Healthcare Conference
Business Wire - Mon Nov 24
·Endo Acquires Rights to Natesto™ Testosterone Nasal Gel
CNW Group - Mon Nov 24
·Trimel Announces Exclusive License Agreement With Endo for NATESTO(TM)
Marketwire - Mon Nov 24
·Endo Acquires Rights to Natesto™ Testosterone Nasal Gel
PR Newswire - Mon Nov 24
·Dr. Reddy’s Announces the Launch of Docetaxel Injection USP
Business Wire - Mon Nov 24
More Latest News...
Sponsor Results
Professional Statistician
All areas of research. Free initial consultation. 877-461-7226
www.OmegaStatistics.com
M/A/R/C Research
Custom Research
www.MARCresearch.com
Industry News & Insights
Learn more about Industry News from the CSG Newsroom.
Newsroom.ChainStoreGuide.com
(What's This?)
  

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Drug Manufacturers - Other Headlines
More Finance RSS Feeds


Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2014 Morningstar, Inc. All Rights Reserved. Company information © 2014 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2014, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?